{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:19:10Z","timestamp":1789510750193,"version":"build-2803163510"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cholestatic liver diseases are a heterogeneous group of hepatobiliary disorders caused by impaired bile formation, secretion, or excretion, leading to hepatocyte injury, biliary inflammation, fibrosis, and eventually cirrhosis. Traditional studies have largely focused on isolated mechanisms, including bile acid toxicity, immune dysregulation, and genetic susceptibility. However, recent advances in metagenomics, metabolomics, and immunology have highlighted the critical role of the gut and biliary microbiota in disease pathogenesis. This review proposes the core concept of a \u201ctripartite interplay among bile composition, biliary microbiome, and host immunity,\u201d integrating the dynamic crosstalk among these three axes in cholestatic liver diseases. Bile composition shapes microbial communities and modulates immune responses through receptors such as FXR and TGR5. In turn, the biliary microbiome regulates bile acid metabolism and immune activity through microbial metabolites. Meanwhile, the host immune system senses microbial signals via pattern-recognition receptors, triggering inflammatory pathways and influencing microbial colonization and metabolism. These reciprocal interactions form complex feedback loops that drive disease progression from early inflammation to chronic fibrosis and cirrhosis. Based on this framework, emerging diagnostic approaches combine microbial signatures, bile acid profiles, and immune markers into multidimensional biomarker systems. Therapeutically, integrated strategies targeting the microbiome, bile acid metabolism, and immune pathways may offer synergistic benefits. Despite challenges including sampling difficulty, interindividual variability, and limitations of current models, future technologies such as single-cell sequencing, spatial transcriptomics, and multi-omics integration may enable precision diagnosis and targeted therapy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1884030","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:43:53Z","timestamp":1784695433000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Microbiota in cholestatic diseases: crosstalk among bile composition, the biliary microbiome, and host immunity"],"prefix":"10.3389","volume":"17","author":[{"given":"Yanni","family":"Yang","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of Anesthesiology, The First Hospital of Lanzhou University","place":["Lanzhou, Gansu, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Ren","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of General Surgery,The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of General Surgery,The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of General Surgery,The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of General Surgery,The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, The First Hospital of Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of General Surgery,The First Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.004","article-title":"Pathogenesis of cholestatic liver disease and therapeutic approaches","volume":"139","author":"Hirschfield","year":"2010","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-009-0081-8","article-title":"Cholestatic liver disease in children","volume":"12","author":"Santos","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031521-025623","article-title":"Pediatric cholestatic diseases: Common and unique pathogenic mechanisms","volume":"19","author":"Sutton","year":"2024","journal-title":"Annu Rev Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111864","article-title":"Impact of microbes on the pathogenesis of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)","volume":"17","author":"Mattner","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136975","article-title":"The role of microbiota in primary sclerosing cholangitis and related biliary Malignancies","volume":"22","author":"\u00d6zdirik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1398466\/v1","article-title":"Microbiome analysis of bile samples in patients with choledocholithiasis and hepatobiliary disorders","volume":"13","author":"Azimirad","year":"2023","journal-title":"Germs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.sempedsurg.2012.05.003","article-title":"Biliary atresia: cellular dynamics and immune dysregulation","volume":"21","author":"Feldman","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.aambs.2016.07.019","article-title":"In sickness and in health: The relationships between bacteria and bile in the human gut","volume":"96","author":"Hay","year":"2016","journal-title":"Adv Appl Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.015","article-title":"The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity","volume":"80","author":"He","year":"2026","journal-title":"J Adv Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12324","DOI":"10.1038\/s41598-019-48784-z","article-title":"Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice","volume":"9","author":"Cabrera-Rubio","year":"2019","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698900","article-title":"Association of gut microbiota and metabolites with disease progression in children with biliary atresia","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26167905","article-title":"Primary biliary cholangitis: Immunopathogenesis and the role of bile acid metabolism in disease progression","volume":"26","author":"Del Barrio","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5494","article-title":"The role of the gut microbiota in bile acid metabolism","volume":"16","author":"Ram\u00edrez-P\u00e9rez","year":"2017","journal-title":"Ann Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s430730","article-title":"The role of inflammation in cholestatic liver injury","volume":"16","author":"Chen","year":"2023","journal-title":"J Inflammation Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.002","article-title":"Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases","volume":"16","author":"Li","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001225","article-title":"The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects","volume":"82","author":"Ronca","year":"2025","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1655287","article-title":"Innate immunity of bile and cholangiocytes in primary biliary cholangitis","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2023.12.005","article-title":"Microbial players in primary sclerosing cholangitis: Current evidence and concepts","volume":"17","author":"\u00d6zdirik","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.888233","article-title":"A systematic review on omics data (metagenomics, metatranscriptomics, and metabolomics) in the role of microbiome in gallbladder disease","volume":"13","author":"Di Carlo","year":"2022","journal-title":"Front Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202403.0945.v1","article-title":"Exploring advanced therapies for primary biliary cholangitis: Insights from the gut microbiota-bile acid-immunity network","volume":"25","author":"Guo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B22","first-page":"17S","article-title":"Bile acid secretion, bile flow and biliary lipid secretion in humans","volume":"12","author":"Hofmann","year":"1990","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/imr.12579","article-title":"Interactions between bile salts, gut microbiota, and hepatic innate immunity","volume":"279","author":"Schubert","year":"2017","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0475-8","article-title":"Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases","volume":"25","author":"Chen","year":"2018","journal-title":"J BioMed Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000450907","article-title":"Disease-associated changes in bile acid profiles and links to altered gut microbiota","volume":"35","author":"Joyce","year":"2017","journal-title":"Dig Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2014.07.007","article-title":"Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases","volume":"38","author":"Calmus","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B31","first-page":"593","article-title":"Mechanisms of cholestasis","volume":"54","author":"Phillips","year":"1986","journal-title":"Lab Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin Liver Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9034-1","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0046-8177(70)80002-8","article-title":"Pathophysiology of cholestasis","volume":"1","author":"Popper","year":"1970","journal-title":"Hum Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2024.11.004","article-title":"Gut microbiome and bile acid interactions: Mechanistic implications for cholangiocarcinoma development, immune resistance, and therapy","volume":"195","author":"Wu","year":"2025","journal-title":"Am J Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","article-title":"Mechanisms of bile acid mediated inflammation in the liver","volume":"56","author":"Li","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000452","article-title":"Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis","volume":"8","author":"Kayashima","year":"2024","journal-title":"Hepatol Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/mop.0000000000001380","article-title":"What's new in pediatric genetic cholestatic liver disease: advances in etiology, diagnostics and therapeutic approaches","volume":"36","author":"Pinon","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2017.06.005","article-title":"An update on the treatment and follow-up of patients with primary biliary cholangitis","volume":"21","author":"Burman","year":"2017","journal-title":"Clin Liver Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.21037\/atm-20-5110","article-title":"The role of bile acids in cholestatic liver injury","volume":"9","author":"Cai","year":"2021","journal-title":"Ann Transl Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.synbio.2021.11.002","article-title":"Analysis of the relationship between bile duct and duodenal microbiota reveals that potential dysbacteriosis is the main cause of primary common bile duct stones","volume":"6","author":"Lyu","year":"2021","journal-title":"Synth Syst Biotechnol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1283737","article-title":"Gallbladder microbial species and host bile acids biosynthesis linked to cholesterol gallstone comparing to pigment individuals","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000997","article-title":"Targeting bile salt homeostasis in biliary diseases","volume":"40","author":"Trampert","year":"2024","journal-title":"Curr Opin Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.07.023","article-title":"Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium","volume":"1864","author":"Strazzabosco","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13738","article-title":"Diagnostic considerations for cholestatic liver disease","volume":"32","author":"Pollock","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-016-2058-6","article-title":"Child with jaundice and pruritus: How to evaluate","volume":"83","author":"Jagadisan","year":"2016","journal-title":"Indian J Pediatr"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1575824","article-title":"Identification and characterization of bile microbiota in patients with biliary obstructive diseases using next-generation sequencing of 16S rRNA and ITS","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1092563","article-title":"A preliminary study of biliary microbiota in patients with bile duct stones or distal cholangiocarcinoma","volume":"2019","author":"Chen","year":"2019","journal-title":"BioMed Res Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/srep17450","article-title":"Metagenomic sequencing of bile from gallstone patients to identify different microbial community patterns and novel biliary bacteria","volume":"5","author":"Shen","year":"2015","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.881489","article-title":"Patients with primary and secondary bile duct stones harbor distinct biliary microbial composition and metabolic potential","volume":"12","author":"Feng","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40168-019-0712-8","article-title":"The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile","volume":"7","author":"Molinero","year":"2019","journal-title":"Microbiome"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i10.1445","article-title":"Gastrointestinal microbiome and cholelithiasis: Current status and perspectives","volume":"29","author":"Dan","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1481112","article-title":"Microbial characteristics of bile in gallstone patients: a comprehensive analysis of 9,939 cases","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Microbiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e94","article-title":"Bile microbiota in patients with pigment common bile duct stones","volume":"36","author":"Kim","year":"2021","journal-title":"J Korean Med Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1532512","article-title":"Preliminary study of biliary microbiota and identification of bacterial species associated with pigmented gallstone formation","volume":"15","author":"Zhang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genomics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020413","article-title":"Gallbladder microbiota in early vertebrates provides evolutionary insights into mucosal homeostasis","volume":"13","author":"Ding","year":"2022","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122073","article-title":"Primary choledocholithiasis occurrence and recurrence is synergetcally modulated by the bile microbiome and metabolome alternations","volume":"331","author":"Liu","year":"2023","journal-title":"Life Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"576","DOI":"10.21037\/atm-22-2247","article-title":"Microbiota analysis with next-generation 16S rDNA gene sequencing in recurrent common bile duct stones","volume":"10","author":"Tan","year":"2022","journal-title":"Ann Transl Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.21037\/atm-20-3295","article-title":"Sphincter of Oddi laxity alters bile duct microbiota and contributes to the recurrence of choledocholithiasis","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.micpath.2015.05.002","article-title":"Cholesterol gallstones and bile host diverse bacterial communities with potential to promote the formation of gallstones","author":"Peng","year":"2015","journal-title":"Microb Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020312","article-title":"Biliary diseases from the microbiome perspective: How microorganisms could change the approach to benign and Malignant diseases","volume":"10","author":"Binda","year":"2022","journal-title":"Microorganisms"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e189","article-title":"Association of microbial dysbiosis with gallbladder diseases identified by bile microbiome profiling","volume":"36","author":"Choi","year":"2021","journal-title":"J Korean Med Sci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41522-024-00506-8","article-title":"Microbial composition associated with biliary stents in patients undergoing pancreatic resection for cancer","volume":"10","author":"Blanco-M\u00edguez","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155479","article-title":"Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents: A prospective cohort study","volume":"11","author":"L\u00fcbbert","year":"2016","journal-title":"PLoS One"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.02.022","article-title":"The gut microbial bile acid modulation and its relevance to digestive health and diseases","volume":"164","author":"Fogelson","year":"2023","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.003","article-title":"Intestinal virome and therapeutic potential of bacteriophages in liver disease","volume":"75","author":"Hsu","year":"2021","journal-title":"J Hepatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0812396","article-title":"Bile acids PKA-dependently induce a switch of the IL-10\/IL-12 ratio and reduce proinflammatory capability of human macrophages","volume":"94","author":"Haselow","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112011","article-title":"Bile acids target mitofusin 2 to differentially regulate innate immunity in physiological versus cholestatic conditions","volume":"42","author":"Che","year":"2023","journal-title":"Cell Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1103735","article-title":"Therapeutic targets for cholestatic liver injury","volume":"20","author":"Woolbright","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2177\/jsci.35.455","article-title":"Pathogenesis of biliary tract injury in primary biliary cirrhosis","volume":"35","author":"Ishibashi","year":"2012","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061281","article-title":"Bile acids activated receptors in inflammatory bowel disease","volume":"10","author":"Biagioli","year":"2021","journal-title":"Cells"},{"key":"B77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11274-025-04395-7","article-title":"The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health","volume":"41","author":"Tyagi","year":"2025","journal-title":"World J Microbiol Biotechnol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: A comprehensive review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1042\/cs20181123","article-title":"Immunological abnormalities in patients with primary biliary cholangitis","volume":"133","author":"Ma","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.17.594680","article-title":"Cholestasis alters polarization and suppressor function of hepatic regulatory T cells","author":"Kudira","year":"2024","journal-title":"bioRxiv"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.07.026","article-title":"Pathogenesis of biliary fibrosis","volume":"1864","author":"Pinzani","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000604","article-title":"Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: A conceptional framework","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.smim.2018.02.008","article-title":"The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function","volume":"37","author":"Sina","year":"2018","journal-title":"Semin Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21106","article-title":"CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system","volume":"16","author":"Dotan","year":"2010","journal-title":"Inflammation Bowel Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114034","article-title":"Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: Therapeutic potential and future directions","volume":"147","author":"Cai","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mr0320-200r","article-title":"Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis","volume":"108","author":"Ronca","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile acid signaling in metabolic and inflammatory diseases and drug development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol Rev"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.b1400327","article-title":"Cross-talk between bile acids and intestinal microbiota in host metabolism and health","volume":"16","author":"Nie","year":"2015","journal-title":"J Zhejiang Univ-Sci B"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14293","article-title":"Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids","volume":"16","author":"Wu","year":"2023","journal-title":"Microb Biotechnol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1411843","article-title":"Biliary atresia: the role of gut microbiome, and microbial metabolites","volume":"14","author":"Feng","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000039","article-title":"The gut microbiota and the metabolic health of the host","volume":"30","author":"Joyce","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: A focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232148","article-title":"Dietary fiber is a critical determinant of pathologic ILC2 responses and intestinal inflammation","volume":"221","author":"Arifuzzaman","year":"2024","journal-title":"J Exp Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250299","article-title":"Bile acid-activated receptors in innate and adaptive immunity: targeted drugs and biological agents","volume":"53","author":"Cheung","year":"2023","journal-title":"Eur J Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6634821","article-title":"Gut immunity and microbiota dysbiosis are associated with altered bile acid metabolism in LPS-challenged piglets","volume":"2021","author":"Xiao","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci9110621","article-title":"Hydrogen-rich water mitigates LPS-induced chronic intestinal inflammatory response in rats via Nrf-2 and NF-\u03baB signaling pathways","volume":"9","author":"Peng","year":"2022","journal-title":"Vet Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404169","article-title":"Defective NOD2 peptidoglycan sensing promotes diet-induced inflammation, dysbiosis, and insulin resistance","volume":"7","author":"Denou","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41598-017-00484-2","article-title":"Nod2 and Nod2-regulated microbiota protect BALB\/c mice from diet-induced obesity and metabolic dysfunction","volume":"7","author":"Rodriguez-Nunez","year":"2017","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00737-9","article-title":"Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis","volume":"54","author":"Han","year":"2022","journal-title":"Exp Mol Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13578-025-01376-z","article-title":"Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation","volume":"15","author":"Seo","year":"2025","journal-title":"Cell Biosci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-02032-4","article-title":"NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate\/S1P receptor 2\/G\u03b1((12\/13))\/MAPK signaling pathway","volume":"99","author":"Hou","year":"2021","journal-title":"J Mol Med (Berl)"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2560019","article-title":"Regulatory roles of intestinal CD4(+) T cells in inflammation and their modulation by the intestinal microbiota","volume":"17","author":"Ma","year":"2025","journal-title":"Gut Microbes"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13092147","article-title":"Human microbiome as an immunoregulatory axis: mechanisms, dysbiosis, and therapeutic modulation","volume":"13","author":"Cort\u00e9s","year":"2025","journal-title":"Microorganisms"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1819155","article-title":"Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation","volume":"12","author":"Wang","year":"2020","journal-title":"Gut Microbes"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00869-6","article-title":"Role of bile acids in inflammatory liver diseases","volume":"43","author":"Evangelakos","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2108655","article-title":"The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management","volume":"14","author":"Nabavi-Rad","year":"2022","journal-title":"Gut Microbes"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28122","article-title":"Natural killer cells regulate T cell immune responses in primary biliary cirrhosis","volume":"62","author":"Shimoda","year":"2015","journal-title":"Hepatology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90327-8","article-title":"Natural killer-cell activity and the response to interferons alpha, beta, and gamma in patients with primary biliary cirrhosis","volume":"84","author":"Matheson","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)80421-3","article-title":"Chronic cholestatic diseases","volume":"32","author":"Poupon","year":"2000","journal-title":"J Hepatol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"de Liso","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-024-01136-9","article-title":"Microbiota-neuroepithelial signalling across the gut-brain axis","volume":"23","author":"Ohara","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/nu17172886","article-title":"Effects of two compound probiotic formulations on gastrointestinal symptoms and gut microbiota: a 4-week randomized, double-blind intervention trial","volume":"17","author":"Qu","year":"2025","journal-title":"Nutrients"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00288-25","article-title":"Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis","volume":"10","author":"Hao","year":"2025","journal-title":"mSystems"},{"key":"B124","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"B126","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijbiomac.2022.02.056","article-title":"Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"205","author":"Fang","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15767","article-title":"FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob\/ob mouse model of NASH","volume":"44","author":"Di Pasqua","year":"2024","journal-title":"Liver Int"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.02.006","article-title":"Microbiome modulation of the host adaptive immunity through bile acid modification","volume":"31","author":"Kuipers","year":"2020","journal-title":"Cell Metab"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2012.03554.x","article-title":"Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway","volume":"136","author":"Ichikawa","year":"2012","journal-title":"Immunology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1638352","article-title":"Interplay between bile acids, gut microbiota, and the tumor immune microenvironment: mechanistic insights and therapeutic strategies","volume":"16","author":"Tong","year":"2025","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.71287","article-title":"Lithocholic acid inhibits dendritic cell activation by reducing intracellular glutathione via TGR5 signaling","volume":"18","author":"Hu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B133","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2139\/ssrn.3528695","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich","year":"2021","journal-title":"J Hepatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.10.009","article-title":"The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats","volume":"185","author":"Verbeke","year":"2015","journal-title":"Am J Pathol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.21037\/atm-21-2631","article-title":"TGR5 protects against cholestatic liver disease via suppressing the NF-\u03baB pathway and activating the Nrf2\/HO-1 pathway","volume":"9","author":"Yang","year":"2021","journal-title":"Ann Transl Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jhbp.560","article-title":"Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis","volume":"25","author":"Gomi","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B140","article-title":"Isolated microorganisms in plastic biliary stents placed for benign and Malignant diseases","volume":"27","author":"Basioukas","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract","volume":"15","author":"Foley","year":"2019","journal-title":"PLoS Pathog"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.230014","article-title":"Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections","volume":"13","author":"Ney","year":"2023","journal-title":"Open Biol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.14218\/jcth.2018.00033","article-title":"Healthy donor fecal microbiota transplantation for recurrent bacterial cholangitis in primary sclerosing cholangitis - a single case report","volume":"6","author":"Philips","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.engmed.2025.100088","article-title":"Targeting the gut microbiota-bile acid axis: therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease","volume":"2","author":"Zhao","year":"2025","journal-title":"EngMedicine"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092120","article-title":"Potential role of inflammation-promoting biliary microbiome in primary sclerosing cholangitis and cholangiocarcinoma","volume":"14","author":"Miyabe","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B148","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Manns","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.70014","article-title":"Bile acid and microbiome interactions in the developing child","volume":"80","author":"Tessier","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.23736\/s2724-5985.23.03590-8","article-title":"Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway","volume":"70","author":"Abenavoli","year":"2024","journal-title":"Minerva Gastroenterol (Torino)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118182","article-title":"The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases","volume":"188","author":"Zhao","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-1","article-title":"Progressive familial intrahepatic cholestasis","volume":"4","author":"Davit-Spraul","year":"2009","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1884030\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:44:07Z","timestamp":1784695447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1884030\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":153,"alternative-id":["10.3389\/fimmu.2026.1884030"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1884030","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1884030"}}